AV���

AV��� is a leader in innovation, providing cutting-edge treatments to improve outcomes and deliver on our promise of personalized care.

Leveraging Digital Technology to Empower Prevention:
“We’re [piloting] electronic medical support to identify patients who have very high cholesterol and flagging them to their PCP [for follow up].”
-Dr. Samuel Kim

Targeting Better Diagnoses and Treatments:
“We are focusing now on microvascular dysfunction, which affects predominantly females, and unfortunately, has historically been difficult to diagnose. We’re currently building a program to decide if certain interventional tests make sense and can help tailor therapy.”
-Dr. Jaya Kanduri

Studying Patients’ Long-Term Health Effects:
"We're participating in an international, multicenter registry looking at patients who receive immune checkpoint inhibitors, which can help us better understand immune checkpoint inhibitor myocarditis.” 
-Dr. Stephanie Feldman